Partnership for Part D Access
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us

Newsroom​ 

Patient Groups Urge Becerra to Maintain Medicare’s Protected Class Benefit

3/1/2021

0 Comments

 
Picture
This post originally appeared in the Washington Post's "Health 202" newsletter on February 26. 2021. 

More than 100 patient advocacy organizations sent a letter to Biden’s health and human services secretary nominee, Xavier Becerra, urging him to protect a Medicare policy that ensures coverage of a wide range of drugs used to treat complex medical conditions
Medicare Part D plans are generally required to provide coverage for at least two drugs in each therapeutic class. But the Centers for Medicare and Medicaid recognized that this may be insufficient for certain drug categories, including many of those used to treat mental health conditions, epilepsy, Parkinson’s disease, lupus, HIV/AIDS, cancer and organ transplants. For six protected classes of drugs, Medicare requires plans to cover most of the drugs in the category.
 
In President Donald Trump’s final days in office, however, his administration announced a proposal that would give participating plans more flexibility in limiting coverage for drugs in the protected categories. The patient advocacy groups are calling on the Biden administration to reverse this policy proposal.
0 Comments



Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    November 2021
    March 2021
    February 2021
    January 2021
    November 2020
    January 2020
    July 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    April 2018
    March 2018
    September 2017
    May 2017
    April 2017
    November 2016
    July 2016

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
E-Mail 
© COPYRIGHT 2018. ALL RIGHTS RESERVED.